Inspire Investing, LLC Dynavax Technologies Corp Transaction History

Inspire Investing, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$13.09 - $14.98 $742,124 - $849,276	56,694 New	56,694 $792,000
Q2 2023 Jul 31, 2023	BUY	$9.85 - $13.17 $14,745 - $19,715	1,497 Added 4.93%	31,856 $411,000
Q1 2023 Apr 24, 2023	BUY	$9.44 - $11.88 $286,588 - $360,664	30,359 New	30,359 $297,000
Q2 2020 Aug 12, 2020	SELL	$2.94 - $9.1 $229 - $709	-78 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$2.27 - $6.2 $177 - $483	78 New	78 $0
Q1 2018 Apr 13, 2018	SELL	$14.65 - $19.9 $791 - $1,074	-54 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$17.3 - $24.08 $934 - $1,300	54	54 $1,000

275

130M

451K

203K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.63B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

Stay updated on Inspire Investing, LLC with notifications on news.